Related Experiment Video
Updated: Jul 19, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The Emerging Role of LncRNA AWPPH in Multiple Cancers: A Review Study
Mohsen Sheykhhasan1, Fateme Dermani2, Nematollah Gheibi3
1Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Abstract:
Long non-coding RNAs (lncRNAs) are transcribed RNA molecules longer than 200 nucleotides in length that have no protein-coding potential. They are able to react with DNA, RNA, and protein. Hence they involve in regulating gene expression at the epigenetic, transcriptional, post-transcriptional, and translational levels. LncRNAs have been proven to play an important role in human malignancies and prognostic outcomes. In this review, we will comprehensively and functionally discuss the role of a novel identified lncRNA, namely lncRNA WAPPH located on human chromosome 2q13, in various cancers. Increasing research studies have shown that lncRNA AWPPH is deregulated in different malignancies, including breast cancer, gastric cancer, colorectal cancer, ovarian cancer, bladder cancer, leukemia, and others. LncRNA WAPPH serves as an oncogene in tumorigenesis and the development of cancer. Moreover, lncRNA AWPPH is involved in numerous biological processes of solid and blood cancers. Taken together, based on our scrutiny analysis, lncRNA AWPPH can be regarded as a putative biomarker for diagnosis or therapeutic target in human malignancies.
Insights
Long non-coding RNA WAPPH (lncRNA WAPPH) acts as an oncogene in various human cancers. This review highlights lncRNA WAPPH
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are key regulators of gene expression across epigenetic, transcriptional, post-transcriptional, and translational levels.
- LncRNAs play a critical role in human malignancies and patient prognosis.
- lncRNA WAPPH, located on chromosome 2q13, is a newly identified lncRNA with significant implications in cancer.
Purpose of the Study:
- To comprehensively review and functionally discuss the role of lncRNA WAPPH in various human cancers.
- To elucidate the oncogenic functions of lncRNA WAPPH in tumorigenesis and cancer progression.
- To explore the involvement of lncRNA WAPPH in the biological processes of both solid and blood cancers.
Main Methods:
- Literature review and analysis of existing research studies on lncRNA WAPPH.
- Functional assessment of lncRNA WAPPH's role in cancer development.
- Examination of lncRNA WAPPH's involvement in diverse cancer types, including breast, gastric, colorectal, ovarian, bladder cancers, and leukemia.
Main Results:
- lncRNA WAPPH is frequently deregulated in a wide spectrum of human malignancies.
- lncRNA WAPPH functions as an oncogene, promoting tumorigenesis and cancer development.
- lncRNA WAPPH is implicated in various biological processes critical to cancer progression in both solid tumors and hematological malignancies.
Conclusions:
- lncRNA WAPPH is a significant oncogene in human cancers.
- lncRNA WAPPH exhibits deregulated expression across numerous cancer types.
- lncRNA WAPPH holds potential as a diagnostic biomarker and therapeutic target for human malignancies.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation

